Hemostemix (CVE:HEM) Trading Up 34.5% – Here’s What Happened

by · The Markets Daily

Hemostemix Inc. (CVE:HEM – Get Free Report) shares were up 34.5% on Thursday . The stock traded as high as C$0.23 and last traded at C$0.20. Approximately 378,687 shares were traded during mid-day trading, a decline of 27% from the average daily volume of 521,979 shares. The stock had previously closed at C$0.15.

Hemostemix Stock Down 7.9 %

The company has a current ratio of 0.04, a quick ratio of 0.48 and a debt-to-equity ratio of -55.07. The firm has a market cap of C$25.50 million, a PE ratio of -5.10 and a beta of 0.20. The company’s 50 day moving average price is C$0.20 and its two-hundred day moving average price is C$0.12.

Hemostemix Company Profile

(Get Free Report)

Hemostemix Inc, a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia.

Recommended Stories